Develops next-generation protein degradation therapies for cancer and inflammatory diseases using a proprietary drug discovery platform.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
BioTheryX is a biopharmaceutical company advancing a portfolio of first-in-class protein degraders, with an initial focus on validated targets in cancer and inflammatory disease. The company leverages its proprietary PRODEGY platform to design and develop next-generation targeted protein degradation therapies, including molecular glues and bifunctional degraders, aiming to transform patient treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
BioTheryX Management Team
Investors
MSD Partners
BioTheryX Valuations & Financials
View real-time NPM data on BioTheryX stock including daily BioTheryX stock price estimates, valuation history, and historical share price information. Access BioTheryX financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track BioTheryX pricing across six independent market signals. Looking for private company due diligence data sources on BioTheryX? Get in touch to learn more.
Similar Companies
like BioTheryX
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Unconventional AI
AI & Machine Learning
Building next‑generation AI hardware and systems to rival conventional compute architectures.
Figur8
Captures 3D skeletal movement and muscle output to objectively assess and improve musculoskeletal performance and recovery.
Replika Software
Provides a community commerce platform that automates commission tracking and link sharing to help brands manage decentralized social selling networks.
Collectable
Web3 & Digital Assets
Provides a platform that lets users buy, sell, and trade fractional equity in rare and high‑value collectible assets.
Golden Plains Wind Farm
Large-scale wind farm development with integrated energy storage system to generate renewable power and enhance electrical grid stability.
DBOS
Enables developers to build resilient, fault-tolerant workflows and AI agents with open source tools for durability, recovery, and scalability.
Kopari Beauty
Consumer
Creates coconut-based skincare designed to nourish, hydrate, and simplify everyday routines.
CubicPV
Produces advanced silicon and perovskite wafers for high-efficiency tandem solar modules, lowering costs and carbon in clean energy.
FAQ
We have answers
BioTheryX stock does not trade on public stock exchanges. BioTheryX stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BioTheryX stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
BioTheryX Stock does not trade on public stock exchanges. In order to sell BioTheryX shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BioTheryX does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view BioTheryX share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for BioTheryX stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BioTheryX stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BioTheryX stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BioTheryX is a private company and has not had an IPO. There is currently no BioTheryX IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to BioTheryX IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
